COVID-19 and VTE: What We Know and What We Don’t Know
A review of what is currently known about the role of inflammation, markers of disease in coagulation studies, pathologic and clinical evidence of thrombosis, and the approach to anticoagulation of COVID-positive hospitalized patients.
By Oren A. Friedman, MD; Eugene Yuriditsky, MD; and James Horowitz, MD, FACC
